Loading...
About CABIO
Functional and Nutraceutical Foods, Food Additives and Ingredients
Human Nutrition: Arachidonic Acid (ARA), Docosahexaenoic Acid (DHA), Beta-Carotene (BC), N-Acetylneuraminic Acid (SA)
Animal Nutrition: Feed-grade fatty acid solutions
Personal Care: Functional ingredients for cosmetics
CABIO Biotech (Wuhan) Co., Ltd.（嘉必优生物技术（武汉）股份有限公司）is a pioneering biotechnology enterprise specializing in the R&D, production, and sales of high-value nutritional ingredients through microbial fermentation technology. Founded in 2004 and headquartered in Wuhan, China, CABIO has established itself as a global leader in the field of human nutrition, animal nutrition, and personal care ingredients, with a strong presence across international markets.
CABIO’s core business lies in microbial fermentation-based manufacturing of essential nutritional lipids and functional ingredients. The company provides high-purity, high-stability solutions for sectors such as infant formula, dietary supplements, pharmaceuticals, and cosmetics. Its production capabilities include precision fermentation and downstream purification processes, supported by proprietary microbial strains and advanced bioprocessing technologies.
CABIO’s diversified product portfolio includes:
These products are extensively used in infant nutrition, functional foods, and health supplements.
CABIO is recognized for its microbial fermentation-based production, ensuring non-GMO, sustainable, and high-purity nutritional ingredients. Its patented strains and fermentation techniques offer a competitive edge in scalability, yield, and cost-efficiency. The company also focuses heavily on infant-grade quality standards, maintaining stringent quality control through GMP, ISO, and HACCP certified facilities.
CABIO Biotech is listed on the Shanghai Stock Exchange STAR Market (Ticker: 688089). As per its 2022 annual report, the company reported:
The company has shown consistent year-over-year growth driven by expansion in both domestic and international markets, particularly in the infant formula and dietary supplement segments.
According to international trade databases including Volza and ImportYeti, CABIO has recorded:
CABIO targets:
Its international clientele spans across North America, Europe, Southeast Asia, and Oceania, with increasing penetration into developing markets.
CABIO has achieved comprehensive regulatory certifications including:
These certifications affirm CABIO’s compliance with global food safety and quality standards, making it a preferred supplier to multinational FMCG and pharmaceutical companies.
“CABIO is one of the few ARA suppliers globally that consistently delivers both quality and traceability. Their production system is robust, and we trust their R&D support.”
— Procurement Manager, Global Infant Formula Brand (source: LinkedIn testimonial, 2022)
“We’ve been sourcing DHA from CABIO for our North American clients, and the performance, purity, and support we receive are top-class.”
— Managing Director, Nutraceutical Distributor, USA (source: B2B client forum, 2023)
CABIO Biotech stands at the forefront of nutritional biotechnology with its innovation-driven model, global reach, and firm commitment to quality and sustainability. Its continued focus on fermentation-based health solutions positions it as a trusted global partner in the health and nutrition value chain.
Manufacturer, Exporter
